morphine
Megjelenés
| Clinical data | |
|---|---|
| Pronunciation | /ˈmɔːrfiːn/ |
| Trade names | Statex, MS Contin, Kadian, Oramorph, M-ESLON, others |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a682133 |
| License data | |
| Pregnancy category |
|
| Dependence liability | High |
| Addiction liability | High |
| Routes of administration | Inhalation, insufflation, by mouth, rectal, subcutaneous, intramuscular, intravenous, epidural, intrathecal |
| Drug class | Opiate |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Bioavailability | 10% (Intranasal) 20–40% (by mouth), 36–71% (rectal), 100% (IV/IM) |
| Protein binding | 30–40% |
| Metabolism | Liver: UGT2B7 |
| Metabolites | • Morphine-3-glucuronide (90%) • Morphine-6-glucuronide (10%) |
| Onset of action | 5 minutes (IV), 15 minutes (IM), 20 minutes (PO) |
| Elimination half-life | 2–3 hours |
| Duration of action | 3–7 hours |
| Excretion | Kidney 90%, bile duct 10% |
| Identifiers | |
| |
| CAS Number |
|
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| PDB ligand | |
| Chemical and physical data | |
| Formula | C17H19NO3 |
| Molar mass | 285.343 g·mol−1 |
| 3D model (JSmol) | |
| Solubility in water | HCl & sulf.: 60 |
| |
| |
| (verify) | |
Főnév
morphine (tsz. morphines)